IGSRT Skin Cancer Treatment in LaPlace, LA
The Only Dermatology Clinic Offering IGSRT in the Greater New Orleans Area
LaPlace Dermatology is proud to be the only dermatology clinic in the Greater New Orleans region offering Image-Guided Superficial Radiation Therapy (IGSRT) — a cutting-edge, non-surgical treatment for non-melanoma skin cancers like basal cell and squamous cell carcinoma.
If you’re looking for an effective alternative to traditional skin cancer surgery with no cutting, stitches, or downtime, IGSRT may be the right solution for you.
What Is IGSRT?
Image-Guided Superficial Radiation Therapy (IGSRT) is an advanced, non-invasive technology used to treat skin cancer by precisely targeting cancerous cells with low-energy radiation. Unlike conventional treatments, IGSRT uses real-time imaging to map the exact depth and size of the tumor, ensuring maximum accuracy and minimal damage to healthy tissue.
This makes it ideal for areas where preserving cosmetic appearance is important, such as the face, ears, or neck.
Benefits of IGSRT
Non-Invasive and Surgery-Free
IGSRT requires no incisions, stitches, or anesthesia. That means no cutting, no bleeding, and no recovery period—making it especially ideal for older patients or those with health conditions that make surgery riskier.
Pain-Free Treatment Experience
Most patients report little to no discomfort during or after treatment. The therapy is gentle on the skin and does not require any downtime, allowing you to resume your normal activities immediately.
Precise, Image-Guided Accuracy
Unlike traditional radiation therapies, IGSRT uses high-resolution ultrasound imaging to map the depth and size of the tumor in real time. This ensures precise targeting of cancer cells while sparing healthy surrounding tissue.
Superior Cosmetic Results
Because there is no cutting or scarring, IGSRT is ideal for areas where appearance matters—such as the face, ears, scalp, or neck. The treatment preserves the natural look and texture of the skin.
Clinically Proven and FDA-Approved
IGSRT is backed by clinical research and approved by the FDA for the treatment of non-melanoma skin cancers. It offers cure rates comparable to Mohs surgery for appropriate candidates.
Safe and Convenient
IGSRT is delivered in a clean, outpatient setting under the supervision of trained professionals. Treatments are quick—typically 15 minutes or less—and are scheduled several times per week over the course of a few weeks.
Who Is a Candidate?
IGSRT is an ideal treatment option for:
Patients with basal cell carcinoma or squamous cell carcinoma
Those who are not good candidates for surgery due to health reasons or personal preference
Individuals with skin cancers in cosmetically sensitive areas (face, nose, ears, scalp)
Anyone seeking a non-invasive, tissue-sparing alternative to traditional skin cancer surgery
